Actively Recruiting

Phase Not Applicable
Age: 18Years - 85Years
All Genders
ID03812016

Comparison of Treatment Outcomes for Blepharoptosis of Various Causes Using a Feedback-Enabled Magnetic Device

Led by E-DA Hospital · Updated on 2025-05-14

40

Participants Needed

2

Research Sites

N/A

Total Duration

On this page

Sponsors

E

E-DA Hospital

Lead Sponsor

N

National Yang Ming Chiao Tung University

Collaborating Sponsor

AI-Summary

What this Trial Is About

Researchers are studying a new feedback-enabled magnetic device designed to temporarily manage blepharoptosis, a condition where the upper eyelid droops. The study aims to evaluate how well the device improves eyelid height, symmetry of blinks, and reduces symptoms like visual field obstruction, blurred vision, and discomfort on the eyelid and surrounding skin. The safety and effectiveness of this device will be compared with outcomes from patients who undergo surgery for the same condition. The device includes near-infrared sensors, a magnetic actuator, an iron sheet for attaching to the affected eyelid, and a biosignal module. During the study, participants will use the device for sessions lasting about 120 minutes each. Researchers will measure the distance the eyelid lifts and assess muscle activity related to eyelid movement. Both subjective sensations and any side effects will be monitored to evaluate the device’s performance. Participants will have their eyelid measurements taken before and after using the device, along with assessments of visual field changes and muscle activity. These evaluations occur shortly after device use and include checking for any skin irritation or discomfort. The study also includes follow-up examinations comparing device use with surgical treatment outcomes at one and six months. The total participation time for each device use session is about two hours, with longer-term follow-up for surgical cases.

CONDITIONS

Brief Title

A Feedback-enabled Magnetic Device for Temporary Management of Blepharoptosis

Who Can Participate

Age: 18Years - 85Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients with ptosis who can understand and follow the study procedures
  • Aged 18 years or older
Not Eligible

You will not qualify if you...

  • Upper eyelid scar, contracture, or fibrosis from prior surgery
  • Psychiatric or mental disorders preventing cooperation
  • Children younger than 18 years old

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Treatment

Duration - Approximately 2 hours per device testing session

Participants use the feedback-enabled magnetic device for temporary management of blepharoptosis. The device testing lasts approximately 120 minutes each time, and efficacy and safety are assessed during and shortly after use.

1 visit (in-person) for device testing and immediate assessments

Follow-up

Duration - 6 months

Participants who undergo surgical intervention are evaluated for efficacy and complications at 1 month and 6 months after surgery.

2 visits (in-person) at 1 month and 6 months post-surgery

Trial Site Locations

Total: 2 locations

1

E-Da Hospital

Kaohsiung City, Taiwan, 82445

Actively Recruiting

2

Shin Kong Wu Ho-Su Memorial Hospital

Taipei, Taiwan

Actively Recruiting

Loading map...

Research Team

C

Ching-Feng Lien, MD, PhD

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

1

Similar Trials

A Study to Evaluate the Efficacy and Safety of STN1013800 Op...

Blepharoptosis

Actively Recruiting

23 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

Efficacy and Safety of a Magnetic Device for Temporary Management of Blepharoptosis: Single-Arm Open-Label Trial.

Ching-Feng Lien, Bor-Shyh Lin, Tzong-Ming Wu...

https://pubmed.ncbi.nlm.nih.gov/40671431